Nuwellis (NUWE) Interest Expenses (2015 - 2025)

Nuwellis (NUWE) reported Interest Expenses of -$46000.0 for Q1 2025, up 89.02% on a YoY basis from -$24335.9 in Q1 2024, and up 89.02% quarter-over-quarter from -$419000.0 in Q1 2024.

Nuwellis (NUWE) Interest Expenses (2015 - 2025) Analysis & Trends

Nuwellis has reported Interest Expenses for 4 years, with the latest figure at -$46000.0 in Q1 2025.

  • For the quarter ending Q1 2025, Interest Expenses rose 89.02% year-over-year to -$46000.0; the trailing twelve-month figure through Dec 2025 stood at -$46000.0 (up 89.02% YoY), and the FY2025 full-year result was $6.4 million, up 3524.29% from the prior year.
  • Interest Expenses for Q1 2025 stood at -$46000.0, up from -$419000.0 in the prior quarter.
  • The five-year high for Interest Expenses was -$46000.0 in Q1 2025, with the low at -$419000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 174.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 148.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 96.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.10 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -46,000.00
Mar 31, 2025 -46,000.00
Mar 31, 2024 -419,000.00
Mar 31, 2024 -419,000.00
Sep 30, 2016 68,000.00
Sep 30, 2016 68,000.00
Jun 30, 2016 1,000.00
Jun 30, 2016 1,000.00
Mar 31, 2016 229,000.00
Mar 31, 2016 229,000.00
Dec 31, 2015 245,000.00
Dec 31, 2015 245,000.00
Sep 30, 2015 280,000.00
Sep 30, 2015 280,000.00
Jun 30, 2015 155,000.00
Jun 30, 2015 155,000.00
Mar 31, 2015 63,000.00
Mar 31, 2015 63,000.00